Literature DB >> 4170945

Clinical evaluation and radiotherapeutic management of Hodgkin's disease and the malignant lymphomas.

H S Kaplan.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 4170945     DOI: 10.1056/NEJM196804182781606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

Authors:  Joachim Yahalom
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 2.  Does radiotherapy still have a place in Hodgkin lymphoma?

Authors:  Joachim Yahalom
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

3.  Mycosis fungoides.

Authors: 
Journal:  Calif Med       Date:  1968-12

4.  Hodgkin's Lymphomas Revisited.

Authors:  J Harrison
Journal:  Calif Med       Date:  1972-12

5.  The case for combined-modality therapy for limited-stage Hodgkin's disease.

Authors:  Christine E Hill-Kayser; John P Plastaras; Zelig Tochner; Eli Glatstein
Journal:  Oncologist       Date:  2012-07-17

6.  [Bone marrow biopsy in malignant lymphomas (author's transl)].

Authors:  H H Hennekeuser; W Möbius; P Obrecht; A Simon; J Slanina
Journal:  Klin Wochenschr       Date:  1974-02-01

7.  Curative radiotherapy in Hodgkin's disease: significance of haematogenous dissemination established by examination of peripheral blood and spleen.

Authors:  M R Halie; J J Seldenrath; H C Stam; H O Nieweg
Journal:  Br Med J       Date:  1972-06-10

8.  Chronic pericardial effusion after mediastinal radiotherapy.

Authors:  S A Gomm; T B Stretton
Journal:  Thorax       Date:  1981-02       Impact factor: 9.139

9.  Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Authors:  P Lagarde; F Bonichon; H Eghbali; I de Mascarel; J Chauvergne; B Hoerni
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

10.  Nodular sclerotic lymphosarcoma. A further review.

Authors:  Y L Millett; M H Bennett; A M Jelliffe; G Farrer-Brown
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.